142 related articles for article (PubMed ID: 28051147)
1. β
Luo J; Liu YH; Luo W; Luo Z; Liu CT
Sci Rep; 2017 Jan; 7():39905. PubMed ID: 28051147
[TBL] [Abstract][Full Text] [Related]
2. A long-acting β2-adrenergic agonist increases the expression of muscarine cholinergic subtype‑3 receptors by activating the β2-adrenoceptor cyclic adenosine monophosphate signaling pathway in airway smooth muscle cells.
Liu YH; Wu SZ; Wang G; Huang NW; Liu CT
Mol Med Rep; 2015 Jun; 11(6):4121-8. PubMed ID: 25672589
[TBL] [Abstract][Full Text] [Related]
3. β2-Agonists upregulate PDE4 mRNA but not protein or activity in human airway smooth muscle cells from asthmatic and nonasthmatic volunteers.
Niimi K; Ge Q; Moir LM; Ammit AJ; Trian T; Burgess JK; Black JL; Oliver BG
Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(3):L334-42. PubMed ID: 22101762
[TBL] [Abstract][Full Text] [Related]
4. Budesonide enhances agonist-induced bronchodilation in human small airways by increasing cAMP production in airway smooth muscle.
Koziol-White C; Johnstone TB; Corpuz ML; Cao G; Orfanos S; Parikh V; Deeney B; Tliba O; Ostrom RS; Dainty I; Panettieri RA
Am J Physiol Lung Cell Mol Physiol; 2020 Feb; 318(2):L345-L355. PubMed ID: 31747297
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.
Yamaya M; Nishimura H; Deng X; Sugawara M; Watanabe O; Nomura K; Shimotai Y; Momma H; Ichinose M; Kawase T
Respir Investig; 2020 May; 58(3):155-168. PubMed ID: 32094077
[TBL] [Abstract][Full Text] [Related]
6. Long-acting β
Altonsy MO; Mostafa MM; Gerber AN; Newton R
Am J Physiol Lung Cell Mol Physiol; 2017 Mar; 312(3):L358-L370. PubMed ID: 28039105
[TBL] [Abstract][Full Text] [Related]
7. Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Nadine L; Kubo H; Nagatomi R
Respir Investig; 2014 Jul; 52(4):251-60. PubMed ID: 24998372
[TBL] [Abstract][Full Text] [Related]
8. A CREB-mediated increase in miRNA let-7f during prolonged β-agonist exposure: a novel mechanism of β
Kim D; Cho S; Woo JA; Liggett SB
FASEB J; 2018 Jul; 32(7):3680-3688. PubMed ID: 29455573
[TBL] [Abstract][Full Text] [Related]
9. Real time analysis of β(2)-adrenoceptor-mediated signaling kinetics in human primary airway smooth muscle cells reveals both ligand and dose dependent differences.
Billington CK; Hall IP
Respir Res; 2011 Jul; 12(1):89. PubMed ID: 21722392
[TBL] [Abstract][Full Text] [Related]
10. Prolonged stimulation of β
Parichatikanond W; Nishimura A; Nishida M; Mangmool S
J Pharmacol Sci; 2018 Nov; 138(3):184-191. PubMed ID: 30322801
[TBL] [Abstract][Full Text] [Related]
11. Long-acting beta 2 agonists suppress IP-10 expression in human bronchial epithelial cells.
Chien JW; Chu YT; Yang SN; Kuo CH; Wang WL; Kuo PL; Jong YJ; Hung CH
J Investig Med; 2012 Oct; 60(7):1048-53. PubMed ID: 22914602
[TBL] [Abstract][Full Text] [Related]
12. Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation.
Noguchi T; Nakagome K; Kobayashi T; Ueda Y; Soma T; Nakamoto H; Nagata M
Allergol Int; 2015 Sep; 64 Suppl():S46-53. PubMed ID: 26344080
[TBL] [Abstract][Full Text] [Related]
13. Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea.
Adner M; Larsson B; Säfholm J; Naya I; Miller-Larsson A
J Pharmacol Exp Ther; 2010 Apr; 333(1):273-80. PubMed ID: 20061444
[TBL] [Abstract][Full Text] [Related]
14. Long-acting β2-adrenoreceptor agonists suppress type 1 interferon expression in human plasmacytoid dendritic cells via epigenetic regulation.
Kuo CH; Yang SN; Tsai YG; Hsieh CC; Liao WT; Chen LC; Lee MS; Kuo HF; Lin CH; Hung CH
Pulm Pharmacol Ther; 2018 Feb; 48():37-45. PubMed ID: 28987803
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β
Scholpa NE; Williams H; Wang W; Corum D; Narang A; Tomlinson S; Sullivan PG; Rabchevsky AG; Schnellmann RG
J Neurotrauma; 2019 Mar; 36(6):962-972. PubMed ID: 30280980
[TBL] [Abstract][Full Text] [Related]
16. Roflumilast N-Oxide in Combination with Formoterol Enhances the Antiinflammatory Effect of Dexamethasone in Airway Smooth Muscle Cells.
Patel BS; Rahman MM; Baehring G; Xenaki D; Tang FS; Oliver BG; Ammit AJ
Am J Respir Cell Mol Biol; 2017 Apr; 56(4):532-538. PubMed ID: 27997807
[TBL] [Abstract][Full Text] [Related]
17. Role of the β
Arif E; Solanki AK; Rahman B; Wolf B; Schnellmann RG; Nihalani D; Lipschutz JH
Pharmacol Rep; 2024 Jun; 76(3):612-621. PubMed ID: 38668812
[TBL] [Abstract][Full Text] [Related]
18. Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone.
Peters SP; Bleecker ER; Canonica GW; Park YB; Ramirez R; Hollis S; Fjallbrant H; Jorup C; Martin UJ
N Engl J Med; 2016 Sep; 375(9):850-60. PubMed ID: 27579635
[TBL] [Abstract][Full Text] [Related]
19. Beta2-adrenergic activation via administration of atenolol/formoterol combination increases contractility and coronary blood flow in isolated rat hearts.
Watson DC; Sargianou M; Leivaditis V; Anagnostopoulos C
Hellenic J Cardiol; 2013; 54(5):341-7. PubMed ID: 24100176
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting.
Perrone V; Sangiorgi D; Buda S; Degli Esposti L
Int J Chron Obstruct Pulmon Dis; 2016; 11():2749-2755. PubMed ID: 27853362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
